Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

The drug will be used in conjunction with other treatments that yield results.

Revolution Medicines' application for a drug to treat metastatic pancreatic cancer was accepted for review by the Food and Drug Administration.

The Fred and Pamela Buffett Cancer Center is now enrolling patients in an expanded access program for investigational drug ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...

A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking ...

An image of a pancreatic cancer cell. Revolution Medicines got a standing ovation in a presentation of the biotech's pancreatic cancer drug. The announcement of a successful late-stage treatment that ...

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.